A study by Di Emidio et al. [45] linking breast cancer treatment, Cyclophosphamide, to altered methylation of Igf2r in mouse offspring suggests that identification of this gene may be a result of treatment rather than cancer process. The gene discussed is IGF2R; the disease is cancer.